Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study.
Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study. Clin Cancer Res. 2013 Mar 15; 19(6):1557-66.
-
Jeffrey A Meyerhardt, M.D.
-
Jeffrey G. Supko, Ph.D.
-
Rakesh K. Jain, Ph.D.
-
Nadine Jackson McCleary, M.D.
-
Dushyant V. Sahani, M.D.
-
Dan Gabriel Duda, Ph.D., D.M.D.
-
Lawrence Scott Blaszkowsky, M.D.
-
David P. Ryan, M.D.
-
Thomas Adam Abrams, M.D.